Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation

Transplantation

Volumn 88, Issue 3, 2009, Pages 429-434

  Valderhaug, Tone G ^a   Jenssen, Trond ^a,b   Hartmann, Anders ^a   Midtvedt, Karsten ^a   Holdaas, Hallvard ^a   Reisæter, Anna V ^a   Hjelmesæth, Jøran ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

Author keywords

Diagnostic test; Immunosuppression; Posttransplant diabetes mellitus

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SENSITIVITY ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 69449107420     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181af1f53     Document Type: Article

References (31)

1. Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415. (Pubitemid 41623405)
2. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496.
3. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603.
4. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588. (Pubitemid 43164454)
5. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178. (Pubitemid 36323115)
6. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979. (Pubitemid 27446762)
7. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: The effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829. (Pubitemid 32257984)
8. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75: SS3.
9. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732. (Pubitemid 32157939)
10. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3: 590. (Pubitemid 36612842)
11. Hagen M, Hjelmesaeth J, Jenssen T, et al. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003; 18: 2154. (Pubitemid 37220325)
12. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31: S12.
13. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 1999; 42: 647.
14. Armstrong KA, Prins JB, Beller EM, et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol 2006; 1: 100.
15. Kuypers DR, Claes K, Bammens B, et al. Early clinical assessment of glucose metabolism in renal allograft recipients: Diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant 2008; 23: 2033. (Pubitemid 351768147)
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183.
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(suppl 1): S5.
18. Saudek CD, Herman WH, Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008; 93: 2447.
19. Ginde AA, Cagliero E, Nathan DM, et al. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med 2008; 23: 1346.
20. Hoban R, Gielda B, Temkit M, et al. Utility of HbA1c in the detection of subclinical post renal transplant diabetes. Transplantation 2006; 81: 379. (Pubitemid 43255723)
21. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881. (Pubitemid 36929359)
22. Boots JM, van Duijnhoven EM, Christiaans MH, et al. Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002; 13: 221.
23. Midtvedt K, Hjelmesaeth J, Hartmann A, et al. Insulin resistance after renal transplantation: The effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004; 15: 3233. (Pubitemid 39578856)
24. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2000; 284: 3043.
25. D'Orazio P, Burnett RW, Fogh-Andersen N, et al. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med 2006; 44: 1486.
26. Peat J, Barton B. Medical statistics. A guide to data analysis and critical appraisal. London, Blackwell Publishing BMJ Books 2005.
27. Hjelmesaeth J, Asberg A, Muller F, et al. New-onset posttransplantation diabetes mellitus: Insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis c virus infection. Curr Diabetes Rev 2005; 1: 1.
28. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001; 47: 153. (Pubitemid 32142912)
29. Winkelmayer WC, Chandraker A. Pottransplantation anemia: Management and rationale. Clin J Am Soc Nephrol 2008; 3(suppl 2): S49.
30. Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 2003; 26: 290. (Pubitemid 36929045)
31. Barr RG, Nathan DM, Meigs JB, et al. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002; 137: 263.